The safety of anti-TNF agents in the elderly.

@article{Migliore2009TheSO,
  title={The safety of anti-TNF agents in the elderly.},
  author={Alberto Migliore and Emanuele Bizzi and Bruno Lagan{\`a} and Lorenzo Altomonte and G Zaccari and Mauro Granata and Marco Canzoni and Bianca Marasini and Marco Sergio Massarotti and Umberto Massafra and Maurizio Ranieri and Raffaele Pilla and L. Schindel Martin and Michele Pezza and Franca Vacca and Antonia G Galluccio},
  journal={International journal of immunopathology and pharmacology},
  year={2009},
  volume={22 2},
  pages={415-26}
}
Rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis are commonly thought of as inflammatory diseases that affect younger individuals. Although the initial presentation of these diseases is common in a patients twenties or thirties, they usually persist for the duration of the patients life. In addition, up to one-third of patients with RA have disease onset after 60 years of age. Anti-TNF-a therapies now have well-recognized safety profiles that have been demonstrated in the… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…